REPL

Replimune Group Inc. Common Stock (REPL)

Stock · NASDAQ · Health Care

$15.5as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$7.06
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Replimune Group Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • REPL
    Replimune Group Inc. Common Stock
    $15.5
    ▼ 0.64%
    Market cap $1.00BP/E
  • MGTX
    MeiraGTx Holdings plc Ordinary Shares
    $13.8
    ▼ 2.40%
    Market cap $1.10BP/E 15.54
    $6.62$15.35
  • SANA
    Sana Biotechnology Inc. Common Stock
    $3.93
    ▼ 3.91%
    Market cap $884.97MP/E
    $2.61$6.55
  • VOR
    Vor Biopharma Inc. Common Stock
    $22.66
    ▼ 3.70%
    Market cap $1.16BP/E
    $6.5$49.95
  • IMTX
    Immatics N.V. Ordinary Shares
    $9.45
    ▲ 0.91%
    Market cap $1.21BP/E
    $5.05$12.41
  • SLDB
    Solid Biosciences Inc. Common Stock
    $9.78
    ▼ 3.46%
    Market cap $789.57MP/E
    $3.79$11.45
  • INBX
    Inhibrx Biosciences Inc. Common Stock
    $123.93
    ▼ 0.00%
    Market cap $1.21BP/E
    $26.19$155.29

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
86.58M
Total value held
$595.23M
Institutional holders
183
Top holders this quarter
  • Unknown11.05M
  • Unknown8.12M
  • Unknown7.36M
  • Unknown6.24M
  • Unknown4.22M
  • Unknown3.78M
  • Unknown2.81M
  • Unknown2.76M
  • Unknown2.34M
  • Unknown2.32M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.